Acutaas Chemicals Ltd. benchmarking: Perfomance to industry peers

Financial

	Acutaas Chemicals	Supriya Lifescience	Aether Industries
Operational Metrics
Financials
5 yr Average ROE	15.72 %	23.4 %	12.44 %
5yr average Equity Multiplier	1.57	1.25	1.36
5yr Average Asset Turnover Ratio	0.74	0.68	0.45
5yr Avg Net Profit Margin	12.98 %	25.52 %	17.79 %
Price to Book	10.49	6.34	4.53
P/E	66.23	35.46	57.5
5yr Avg Cash Conversion Cycle	55.02 Days	-10.96 Days	173.8 Days
Inventory Days	64.12 Days	56.1 Days	139.35 Days
Days Receivable	90.06 Days	57.43 Days	113.43 Days
Days Payable	127.33 Days	113.66 Days	100.34 Days
5yr Average Interest Coverage Ratio	25.42	60.74	19.69
5yr Avg ROCE	20.01 %	30.51 %	15.21 %
5yr Avg Operating Profit Margin	20.92 %	36.15 %	26.99 %
5 yr average Debt to Equity	0.23	0.06	0.23
5yr CAGR Net Profit	24.06 %	8.75 %	7.78 %
5yr Average Return on Assets	9.8 %	17.81 %	8.26 %
Shareholdings
Promoter Holding	32.66 %	68.3 %	75.0 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-6.75 %	0.06 %	-12.09 %
Change in Mutual Fund Holding (3 Yrs)	12.5 %	-1.7 %	4.44 %

Business

	Acutaas Chemicals	Supriya Lifescience	Aether Industries
Product Wise Break-Up	Product Wise Break-Up Pharma Intermediates 80.02 Specialty Chemicals 19.98 Pharmaceuticals 0 2-Methoxy-6-Chlorotoluene (MCT) 0 0 0 0 Thiophene-2-Ethanol (T2E) 0 4-(2-Methoxyethyl) Phenol (4MEP) 0 4`-Methyl-2-Cyanobiphenyl (OTBN) 0 Bifenthrin Alcohol (BFA) 0 CRAMS 0	Product Wise Break-Up Pharma Intermediates 0 Specialty Chemicals 0 4`-Methyl-2-Cyanobiphenyl (OTBN) 0 Pharmaceuticals 100.0 4-(2-Methoxyethyl) Phenol (4MEP) 0 0 0 2-Methoxy-6-Chlorotoluene (MCT) 0 Bifenthrin Alcohol (BFA) 0 Thiophene-2-Ethanol (T2E) 0 0 CRAMS 0	Product Wise Break-Up Pharma Intermediates 0 Specialty Chemicals 0 4`-Methyl-2-Cyanobiphenyl (OTBN) 0 Pharmaceuticals 0 4-(2-Methoxyethyl) Phenol (4MEP) 16.01 0 3-Methoxy-2-Methyllenzoyl Chloride (MMBC) 10.74 2-Methoxy-6-Chlorotoluene (MCT) 0 Bifenthrin Alcohol (BFA) 15.18 Thiophene-2-Ethanol (T2E) 0 0 CRAMS 0 Others 58.07
Location Wise Break-Up	Location Wise Break-Up India 44.0 Finland 18.6 Italy 14.2 China 3.9 Germany 3.4 Spain 2.5 Israel 1.9 France 0 North America 0 LAC 0 Europe 0 Mexico 0 Japan 0 Netherlands 0 Belgium 0 USA 0 Others 11.5	Location Wise Break-Up Spain 0 Germany 0 France 0 Europe 41.0 Mexico 0 USA 0 Japan 0 North America 4.0 Netherlands 0 China 0 Finland 0 Israel 0 Italy 0 India 0 Latin America 17.0 Belgium 0 Others 38.0	Location Wise Break-Up Spain 4.6 Germany 6.32 France 0 Europe 0 Mexico 10.49 USA 6.81 Japan 2.37 North America 0 Netherlands 0.78 China 1.59 Finland 0 Israel 0 Italy 1.77 India 60.51 LAC 0 Belgium 0 Others 4.76
Therapeutic Area Break-Up	Therapeutic Area Break-Up Anti-depressant 27.99 Anti-retroviral 21.36 Anti-coagulant 6.73 Anti-malarial 0 Anti-allergic 0 Anti-Asthmatic 0 Vitamins 0 Anti-histamine 0 Analgesic/Anesthetic 0 Others 43.92	Therapeutic Area Break-Up Analgesic/Anesthetic 53.0 Anti-histamine 13.0 Anti-malarial 0 Anti-coagulant 0 Anti-depressant 0 Vitamins 11.0 Anti-Asthmatic 6.0 Anti-allergic 5.0 Anti-retroviral 0 Others 12.0	-
Verticals	Verticals Oil & Gas 0 Photography 0 Coatings 0 Material Science 0 Agro 0 Pharma 0 Others 100	-	Verticals Coatings 3.32 Photography 7.21 Material Science 16.87 Pharma 35.1 Agro 11.11 Oil & Gas 19.18 Others 7.21
Acute vs Chronic	Acute vs Chronic Chronic 95.0 Acute 5.0	-	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise India 86.46 Others 13.54	-	-
API Break-Up	API Break-Up Trazodone 25.5 Dolutegravir 24.15 Oxcarbamazepine 6.69 Vortioxetine 4.87 Nintedanib 4.51 Zonisamide / Warfarin 4.29 Entacapone 3.52 Darulutamide 2.88 Celecoxib 2.81 Diclofenac Sodium 2.76 Quetiapine 2.63 Rivaroxaban 1.17 Dabigatran 1.02 Pazopanib 0.98 Apixaban 0.88 Others 11.34	-	-

Acutaas Chemicals Ltd.

Acutaas Chemicals Ltd.

Financial

Business

SIGN UP FOR FREE